In the present study, we examined the uterine relaxant activity of 4-chloro-7-trifluoromethyl-10H-benzo[4,5]furo[3,2-b]indole-1-carboxylic acid (TBIC), a putative opener of the large conductance Ca2+-activated K+ (BKCa) channel. TBIC concentration-dependently inhibited spontaneous uterine contractions (EC50 = 4.63 µmol/l; Emax = 94.85 ± 1.85%; 100 µmol/l, n = 6). It also reduced contractions induced by oxytocin (EC50 = 4.10 µmol/l; Emax = 84.3 ± 3.83%; 100 µmol/l, n = 6), prostaglandin F2α (EC50 = 2.14 µmol/l; Emax = 73.70 ± 5.21%; 100 µmol/l, n = 6) and acetylcholine (EC50 = 4.37 µmol/l; Emax = 83.67 ± 4.82; 100 µmol/l, n = 6). TBIC decreased KCl (20 mmol/l) -induced contractions (EC50 = 3.04 µmol/l; Emax = 94.0 ± 3.12%; 100 µmol/l, n = 6) indicating its K+ channel opening activity. BKCa channel blockers penitrem A (100 nmol/l) and tetraethylammonium chloride (1 mmol/l) attenuated the inhibitory activities of TBIC (p < 0.001) but not other K+ channel blockers such as barium chloride and glibenclamide (KIR and KATP channel blockers, respectively). These results demonstrate the uterine relaxant effects of TBIC in a mechanism of action largely referable to the potentiation of the BKCa channels. We have provided evidence for the potential use of TBIC as a tocolytic agent and support for the utility of BKCa channel openers in pathophysiologic conditions involving smooth muscle hyperactivity.